Jon has been reporting on stock markets for over twenty-five years for audio text companies (remember them?!), newswires, and websites. He helped set up MarketEye News for ICV/Topic in the 1990’s before moving on to become a Markets reporter at AFX News. After over 10 years, which saw him rise to the dizzy heights of Markets Editor at AFX, the firm’s acquisition by Thomson Corp and subsequent takeover of Reuters, he moved on in 2012. Prior to Proactive Investors, he was News Editor for thisismoney.co.uk, the Mail Online’s financial website.
In a brief trading update, the FTSE 100-listed medical technology group said its third-quarter revenue was US$1.169bn, up 2% on a reported basis and 3% on an underlying basis
E-therapeutics believes it is now focused on the right activities
Russ Mould, investment director at AJ Bell thinks the short-selling squeeze now looks to be over, with data suggesting only 1.4% of Ocado’s shares had been sold short, in early August, down from more than 21% in summer 2016
In a brief statement, the FTSE 100-listed company reaffirmed "its current focus on the GCC (Gulf Cooperation Council) market for capital deployment”
Mediclinic’s chief executive Ronnie van der Merwe commented: "The poor performance in Switzerland more than outweighed the revenue growth and margin expansion delivered by the Southern Africa and the Middle East divisions"
The AIM-listed firm said it issued 76,666,666 new ordinary shares at a price of 1.50p each in the placing undertaken by the company's broker, Novum Securities
Speedboat is the first device developed for use with the Welsh company's CROMA generator, which allows doctors to carry out surgical procedures without the need to puncture the skin
The proposed offer, which would value the AIM-listed maker of skin lifting, collagen stimulation treatments and dermal fillers at roughly £161.2mln